CBT – Dividend Returns, History & Calculator

Dividend Contender 14 Years

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing ag

...

Company Info

Symbol CBT
Company Cabot Corporation
Sector Basic Materials
Industry Specialty Chemicals
Website Visit
Market Cap $3,641.8M

Price Data

Price $68.45
Price Change +0.36
Price Change % +0.53%
Next Earnings Nov 3, 2025
Low (52W) $66.50
High (52W) $117.46

Dividend Data

Div Yield 262.97%
5Y Avg Yield 209.94%
Current Div $0.450
Payouts/Year 4
Annualized $1.800
Previous Div $0.450
Ex-Date Aug 29, 2025

Growth Rates

Chowder Number 7.3
DGR 1Y 6.0%
DGR 3Y 5.9%
DGR 5Y 4.7%
DGR 10Y 7.2%

Total Returns

TTR 1Y - With Specials -38.2%
TTR 3Y - With Specials 5.6%
TTR 1Y - No Specials -38.2%
TTR 3Y - No Specials 5.6%

Fair Value

Fair Value (P/E 10) $60.99
FV (P/E 10) % 12.0%
Fair Value (Peter Lynch) $38.20
FV (Peter Lynch) % 79.0%
Fair Value (Blended) $61.71
FV (Blended) % 11.0%

Financial Metrics

Revenue 1Y 1.6%
NPM 0.0%
CF/Share $12.22
ROE 29.4%
Current R 2.1x
Debt/Capital 42.0%
ROTC 0.0%
P/E 9.0x
P/BV 2.4x
PEG 1.15
📊 Financial data last updated: October 16, 2025 9:54 am

Calculate your CBT Dividend Returns

Quickly and easily calculate CBT dividend yield using our CBT calculator. Adjust the fields below to see how your CBT investments snowball over time.

Show Idealized Scenario (Assumes all future extra investments and dividends are made on Day 1 and reinvested instantly — this creates a best-case scenario for compounding growth.)

Portfolio Growth Over Time

Data last updated: October 16, 2025 7:27 pm

Year-by-Year Portfolio Growth (Realistic DRIP Scenario)

YearStart BalanceStart SharesShare PriceDividend / ShareDividend YieldYield on CostAnnual DividendTotal DividendsEnd SharesEnd Balance
1$10,000146$68.48$0.452.63%2.63%$285$285168$11,485
2$12,215168$72.83$0.482.65%2.82%$348$633189$13,762
3$14,637189$77.46$0.522.68%3.03%$417$1,050210$16,253
4$17,286210$82.38$0.562.71%3.26%$493$1,543230$18,979
5$20,185230$87.61$0.602.74%3.50%$579$2,121251$21,964
6$23,359251$93.18$0.642.76%3.76%$673$2,794271$25,232
7$26,835271$99.10$0.692.79%4.04%$778$3,572291$28,812
8$30,643291$105.39$0.742.82%4.34%$894$4,466311$32,737
9$34,817311$112.09$0.802.85%4.66%$1,023$5,490330$37,040
10$39,393330$119.21$0.862.88%5.01%$1,167$6,656350$41,759

CBT Dividend History

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/29/202508/29/2025$0.4502.16%2.21%$81.56
05/30/202505/30/2025$0.4502.33%2.41%$74.69
02/28/202502/28/2025$0.4302.00%2.00%$86.00
11/29/202411/29/2024$0.4301.54%1.57%$109.62
08/30/202408/30/2024$0.4301.58%1.64%$105.11
05/31/202405/31/2024$0.4301.59%1.68%$102.30
02/22/202402/22/2024$0.4001.94%1.94%$82.61
11/22/202311/22/2023$0.4002.03%2.07%$77.32
08/24/202308/24/2023$0.4002.22%2.31%$69.24
05/25/202305/25/2023$0.4002.16%2.29%$69.75
02/23/202302/23/2023$0.3701.89%1.89%$78.12
11/23/202211/23/2022$0.3702.01%2.01%$73.80
08/25/202208/25/2022$0.3701.91%1.91%$77.46
05/26/202205/26/2022$0.3702.02%2.04%$72.39
02/24/202202/24/2022$0.3702.00%2.05%$72.10
11/24/202111/24/2021$0.3702.43%2.54%$58.34
08/26/202108/26/2021$0.3502.65%2.65%$52.83
05/27/202105/27/2021$0.3502.21%2.21%$63.37
02/25/202102/25/2021$0.3502.81%2.81%$49.80
11/25/202011/25/2020$0.3503.21%3.21%$43.59
Page 1 of 1

CBT 10-yr Total Return ($10,000 invested)

This analysis of CBT demonstrates the power of dividend reinvestment over a 10-year period with a $10,000 initial investment. The dividend reinvestment strategy delivered a 9.4% CAGR, representing moderate long-term performance. Recent 5-year performance has been particularly strong at 16.7% annually, outpacing the 10-year average. The DRIP strategy provided 20% more total return compared to collecting dividends as cash, highlighting the compounding effect of reinvestment.

With DRIP No DRIP

Total Return with and without DRIP (CBT)

Over the selected period, investing $10,000 in CBT would grow to $31,506 with DRIP (215.1%), and $28,170 without DRIP (181.7%).

CBT Dividend Reinvestment Snowball

Investing $10,000 + $100/mo in CBT with historic price growth (6.35%) and dividend growth (7.42%) produces dramatically different outcomes depending on whether you reinvest dividends.

After 20 Years

Your Investment: $34,000

With DRIP

Portfolio: $127,753

Annual Dividend: $4,099

Yield on Cost: 12.06%

Total Dividends: $30,044

No DRIP

Portfolio: $104,125

Total Dividends: $22,435

After 30 Years

Your Investment: $46,000

With DRIP

Portfolio: $346,921

Annual Dividend: $12,299

Yield on Cost: 26.74%

Total Dividends: $101,936

No DRIP

Portfolio: $229,759

Total Dividends: $61,895

Milestones on the way

By year 13, the compounding really starts to show. Your total dividends collected reach $10,996 against a total investment of $25,600. At this point, your portfolio is throwing off $1,830 per year in dividends alone.

By year 17, the annual dividend climbs to around your initial contribution. For a starting investment of $10,000, the yearly dividend now sits at approximately $2,921, a powerful “income on autopilot” milestone.

After two decades, cumulative dividends total $30,044 versus $34,000 invested, nearly a 88% recovery of capital purely from income. Yield on cost reaches 12.06%.

At year 25, the income engine takes over. The portfolio’s annual dividend of $7,124 is greater than total contributions to date ($40,000), and cumulative dividends exceed $56,382.

By year 30, the DRIP snowball is in full force. Yearly income reaches $12,299, cumulative dividends total $101,936, and the DRIP portfolio value stands at $346,921, compared with $229,759 if dividends weren’t reinvested.

How we estimate these numbers

We use the latest calculator inputs for CBT, price $68.48, dividend per period $0.45 (4×/year), along with historic growth assumptions: price growth 6.35% and dividend growth 7.42% annually.

We simulate month by month for 30 years. Every month, a $100 contribution is added and converted to shares at that month’s price. Dividends are paid roughly evenly across the year based on the dividend frequency; in the DRIP path, each payout immediately buys additional shares at the then-current price. In the No‑DRIP path, dividends accrue as cash. Prices grow using a monthly rate derived from the annual price growth. Dividends per share increase once per year at the annual dividend growth rate.

This model isn’t investment advice; it’s a simple, transparent framework that illustrates how reinvesting dividends can accelerate both income and total return over time.

Projected Future Returns & Dividends for CBT

Based on past 10-year performance, here are CBT growth metrics:

Share price CAGR of +9.50%
Dividend CAGR of +7.18%

Using CBT CAGR metrics, we can estimate that your initial $10,000 investment, over the next 10 years, should grow as follows:

CBT (DRIP)CBT (No DRIP)
Current Price$68.48$68.48
Start Shares146.03146.03
Start Value$10,000$10,000
After 10 years:
Final Share Count184.04146.03
Dividends Payment$3.60$3.60
Annual Dividends$649$526
Yield on cost6.49%5.26%
Share Price$169.67$169.67
Total Dividends$4,441$3,925
Final Value$31,227$28,701

Estimated Future Value + Dividends – CBT

Dividend History: Payments & Yield

Shows quarterly dividend payments with trailing yield and a 5-year rolling average overlay. Use the range pills to switch the visible period.

Yield Dividend

Dividend Growth

Lifetime quarterly dividend amounts, with range controls for 1Y/2Y/5Y/10Y. Useful to visualize the cadence and pace of dividend increases over time.

Dividend

Dividend Payments & Yield

Quarterly dividends with TTM yield and a 5‑year rolling average overlay. Helps compare current yield versus recent history across different ranges.

Dividend 5-yr Rolling AVG Yield

CBT Dividend History

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/29/202508/29/2025$0.4502.16%2.21%$81.56
05/30/202505/30/2025$0.4502.33%2.41%$74.69
02/28/202502/28/2025$0.4302.00%2.00%$86.00
11/29/202411/29/2024$0.4301.54%1.57%$109.62
08/30/202408/30/2024$0.4301.58%1.64%$105.11
05/31/202405/31/2024$0.4301.59%1.68%$102.30
02/22/202402/22/2024$0.4001.94%1.94%$82.61
11/22/202311/22/2023$0.4002.03%2.07%$77.32
08/24/202308/24/2023$0.4002.22%2.31%$69.24
05/25/202305/25/2023$0.4002.16%2.29%$69.75
02/23/202302/23/2023$0.3701.89%1.89%$78.12
11/23/202211/23/2022$0.3702.01%2.01%$73.80
08/25/202208/25/2022$0.3701.91%1.91%$77.46
05/26/202205/26/2022$0.3702.02%2.04%$72.39
02/24/202202/24/2022$0.3702.00%2.05%$72.10
11/24/202111/24/2021$0.3702.43%2.54%$58.34
08/26/202108/26/2021$0.3502.65%2.65%$52.83
05/27/202105/27/2021$0.3502.21%2.21%$63.37
02/25/202102/25/2021$0.3502.81%2.81%$49.80
11/25/202011/25/2020$0.3503.21%3.21%$43.59
08/27/202008/27/2020$0.3503.68%3.68%$38.00
05/28/202005/28/2020$0.3503.83%3.83%$36.53
02/27/202002/27/2020$0.3503.79%3.79%$36.94
11/27/201911/27/2019$0.3502.90%2.94%$47.64
08/29/201908/29/2019$0.3503.45%3.55%$39.47
05/30/201905/30/2019$0.3503.27%3.42%$40.93
02/21/201902/21/2019$0.3302.83%2.83%$46.59
11/29/201811/29/2018$0.3302.69%2.72%$48.50
08/30/201808/30/2018$0.3301.99%2.03%$64.95
05/24/201805/24/2018$0.3302.17%2.25%$58.70
02/22/201802/22/2018$0.3151.97%1.97%$63.82
11/22/201711/22/2017$0.3152.05%2.08%$60.67
08/23/201708/23/2017$0.3152.37%2.42%$51.99
05/24/201705/24/2017$0.3152.29%2.38%$53.00
02/22/201702/22/2017$0.3002.07%2.07%$58.09
11/22/201611/22/2016$0.3002.16%2.31%$51.97
08/24/201608/24/2016$0.3002.10%2.43%$49.44
05/25/201605/25/2016$0.3002.11%2.64%$45.43
02/24/201602/24/2016$0.2202.02%2.02%$43.53
11/24/201511/24/2015$0.2202.04%2.04%$43.04
08/26/201508/26/2015$0.2202.68%2.68%$32.84
05/27/201505/27/2015$0.2202.08%2.08%$42.30
02/25/201502/25/2015$0.2201.91%1.91%$46.18
11/25/201411/25/2014$0.2201.86%1.90%$46.29
08/27/201408/27/2014$0.2201.55%1.62%$54.20
05/28/201405/28/2014$0.2201.46%1.56%$56.30
02/26/201402/26/2014$0.2001.48%1.48%$54.01
11/26/201311/26/2013$0.2001.64%1.64%$48.71
08/28/201308/28/2013$0.2002.01%2.01%$39.86
05/29/201305/29/2013$0.2001.97%1.97%$40.53
02/27/201302/27/2013$0.2002.18%2.18%$36.76
11/28/201211/28/2012$0.2002.09%2.14%$37.35
08/29/201208/29/2012$0.2002.17%2.28%$35.02
05/30/201205/30/2012$0.2001.94%2.10%$38.15
02/22/201202/22/2012$0.1801.76%1.76%$41.02
11/22/201111/22/2011$0.1802.39%2.39%$30.10
08/25/201108/25/2011$0.1802.30%2.30%$31.24
05/25/201105/25/2011$0.1801.76%1.76%$40.97
02/23/201102/23/2011$0.1801.72%1.72%$41.81
11/23/201011/23/2010$0.1802.10%2.10%$34.35
08/25/201008/25/2010$0.1802.61%2.61%$27.63
05/26/201005/26/2010$0.1802.66%2.66%$27.04
02/24/201002/24/2010$0.1802.46%2.46%$29.30
11/24/200911/24/2009$0.1803.16%3.16%$22.80
08/26/200908/26/2009$0.1803.52%3.52%$20.46
05/27/200905/27/2009$0.1804.33%4.33%$16.64
02/25/200902/25/2009$0.1806.64%6.64%$10.84
11/25/200811/25/2008$0.1803.69%3.69%$19.52
08/27/200808/27/2008$0.1802.68%2.68%$26.82
05/28/200805/28/2008$0.1802.29%2.29%$31.43
02/27/200802/27/2008$0.1802.50%2.50%$28.80
11/28/200711/28/2007$0.1802.23%2.23%$32.34
08/29/200708/29/2007$0.1801.82%1.82%$39.54
05/23/200705/23/2007$0.1801.48%1.53%$47.18
02/21/200702/21/2007$0.1801.44%1.52%$47.37
11/21/200611/21/2006$0.1801.55%1.69%$42.71
08/23/200608/23/2006$0.1602.03%2.03%$31.53
05/24/200605/24/2006$0.1601.94%1.94%$33.02
02/22/200602/22/2006$0.1601.73%1.73%$37.00
11/22/200511/22/2005$0.1601.88%1.88%$34.08
08/24/200508/24/2005$0.1601.93%1.93%$33.14
05/25/200505/25/2005$0.1602.18%2.22%$28.86
02/23/200502/23/2005$0.1601.78%1.83%$34.90
11/23/200411/23/2004$0.1601.67%1.75%$36.48
08/25/200408/25/2004$0.1501.53%1.53%$39.25
05/26/200405/26/2004$0.1501.69%1.69%$35.55
02/25/200402/25/2004$0.1501.71%1.77%$33.90
11/25/200311/25/2003$0.1501.93%2.07%$28.95
08/27/200308/27/2003$0.1502.02%2.24%$26.77
05/28/200305/28/2003$0.1301.80%1.80%$28.95
02/26/200302/26/2003$0.1302.36%2.36%$22.00
11/26/200211/26/2002$0.1302.17%2.17%$23.96
08/28/200208/28/2002$0.1302.16%2.16%$24.09
05/29/200205/29/2002$0.1302.07%2.07%$25.09
02/20/200202/20/2002$0.1301.54%1.54%$33.68
11/28/200111/28/2001$0.1301.37%1.43%$36.37
08/29/200108/29/2001$0.1301.22%1.32%$39.45
05/23/200105/23/2001$0.13037.01%1.39%$37.32
02/21/200102/21/2001$0.11040.27%1.28%$34.25
11/21/200011/21/2000$0.11054.90%1.75%$25.13
10/02/200010/02/2000$13.4672.83%284.37%$18.94
08/23/200008/23/2000$0.1101.17%1.17%$37.72
05/24/200005/24/2000$0.1101.61%1.61%$27.31
02/23/200002/23/2000$0.1101.92%1.92%$22.88
Page 1 of 1

Dividend Payout Ratio

Tracks the percentage of earnings paid out as dividends each quarter. Lower and stable ratios often indicate safer, more sustainable payouts.

Payout Ratio

Dividend to Free Cash Flow Ratio

Shows dividends as a percentage of free cash flow. Consistently high values may signal limited reinvestment capacity or potential dividend risk.

Dividend/FCF Ratio

Share Price

Historical closing price with range controls. Table view includes quarter‑over‑quarter and year‑over‑year changes for additional context.

CBT Price

Price to Earnings

CBT trades at a 33.1x price-to-earnings ratio. This elevated valuation suggests investors expect strong future growth.

Price to Sales

CBT trades at a 4.5x price-to-sales ratio, providing insight into market valuation relative to revenue generation.

Revenue

CBT generated $0.9B in revenue.

Net Income

CBT reported $0.0B in net income. Net income has declined by 100% over the period.

Revenue vs Net Income

CBT generated $0.9B in revenue with net income of $0.0B, representing a 0.0% net profit margin.

Gross Profit

CBT achieved $0.7B in gross profit, showing revenue after direct production costs.

Operating Income

CBT generated $0.3B in operating income, representing profit from core business operations.

EBITDA

CBT generated $0.4B in EBITDA, measuring operational profitability before interest, taxes, depreciation, and amortization.

Operating Cash Flow

CBT generated $0.0B in operating cash flow, demonstrating the company’s ability to convert earnings into cash.

Free Cash Flow

CBT generated $0.0B in free cash flow. Free cash flow has decreased by 177% over the period.

Free Cash Flow / Share

CBT generates $-0.61 in free cash flow per share. FCF per share has declined by 177% over the period.

Earnings Per Share (EPS)

CBT reported $0.00 in earnings per share. EPS has declined by 100% over the period.

Return on Equity (ROE)

CBT delivered a 0.0% return on equity, indicating how effectively the company generates returns for shareholders.

Return on Assets (ROA)

CBT achieved a 0.0% return on assets, measuring how efficiently the company uses its assets to generate profit.

Net Profit Margin

CBT maintains a 0.0% net profit margin, showing the percentage of revenue retained as profit after all expenses.

Gross Profit Margin

CBT operates with a 77.4% gross profit margin, reflecting pricing power and cost efficiency in core operations.

Cash & Debt

CBT holds $0.1B in cash against $0.0B in debt, resulting in a net cash position of $0.1B.

Shares Outstanding

CBT has 0.1B shares outstanding.

Stock-Based Comp

CBT reported $0.0B in stock-based compensation.

FCF vs Stock Based Comp

CBT generated $0.0B in free cash flow while spending $0.0B on stock-based compensation, representing -71% of FCF.

FCF vs FCF / Share

CBT reported $0.0B in free cash flow, translating to $-0.61 per share.

Revenue: Actual + Estimates

This chart tracks CBT revenue: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

EPS: Actual + Estimates

This chart tracks CBT eps: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

Net Income: Actual + Estimates

This chart tracks CBT net income: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

EBITDA: Actual + Estimates

This chart tracks CBT ebitda: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.

Disclaimer: The information on this page is for educational and entertainment purposes only and does not constitute financial advice. Do your own research and consult a qualified financial advisor before making investment decisions. Data sources include Yahoo Finance and other third-party providers and may contain errors or delays.

Download now

Get your dividend champions spreadsheet.